The marijuana “green rush” has overtaken Wall Street, as investors jump aboard marijuana stocks the way frenzied gold miners descended on San Francisco in the 19th century. As with the gold rush of that bygone era, some green rush investors will get rich… and others will go bust. But the… Read More

An investment truism: invest in products that people will always want, in good times or bad. And when it comes to providing a product that people crave the world over, alcoholic beverage makers pass the test. Constellation Brands (NYSE: STZ) is one of the world’s leading purveyors of beer, wine… Read More

For investors, it pays to be contrarian. A much-ballyhooed stock can sometimes mask inherent weaknesses. It’s our job to find the real story behind the headlines and press releases. Which brings us to Wall Street darling Cognizant Technology Solutions (NSDQ: CTSH). As information technology (IT) continues to thrive, CTSH is… Read More

GW Pharmaceuticals (NSDQ: GWPH), based in the United Kingdom, is perhaps the best-known marijuana biotech that’s developing cannabinoid medical treatments. Should you invest? Read More

Investors have been eagerly awaiting October 17, the date that recreational pot use is legalized in Canada. But will this highly anticipated event prove anti-climactic? Read More

The sales launch of legal marijuana in California has sent related stocks flying, but investors should be careful. Rather than bet on one or two companies, it may be better to do this. Read More

Readers asked about social media risks, problematic defense contractor cash flows, the best pot investments, and energy sector indebtedness. Read More